Clinical trials
Not yet recruiting Lung Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Henry Ford Health System | 2 |
| Massachusetts General Hospital | 2 |
| Roswell Park Cancer Institute | 2 |
| Beijing Pearl Biotechnology Limited Liability Company | 1 |
| Carcinex Inc | 1 |
| Cell>Point LLC | 1 |
| Duke University | 1 |
| Hackensack Meridian Health | 1 |
| Harvard Medical School (HMS and HSDM) | 1 |
| Jonathan Riess | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 34 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Breast Neoplasms | 4 |
| Disease | 4 |
| Head and Neck Neoplasms | 3 |
| Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Dyspnea | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.